Remyelination‐oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma

K Liu, Y Yang, Z Wu, C Sun, Y Su, N Huang, H Wu, C Yi… - Glia, 2024 - Wiley Online Library
As one of the top causes of blindness worldwide, glaucoma leads to diverse optic
neuropathies such as degeneration of retinal ganglion cells (RGCs). It is widely accepted …

Natural compounds and retinal ganglion cell neuroprotection

LA Morrone, L Rombolà, MT Corasaniti… - Progress in brain …, 2015 - Elsevier
Glaucoma, the second leading cause of blindness in the world, is a chronic optic neuropathy
often associated with increased intraocular pressure and characterized by progressive …

[HTML][HTML] Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal …

Y Wang, MM Brahma, K Takahashi… - NeuroMolecular …, 2024 - Springer
Normal tension glaucoma (NTG) is a progressive neurodegenerative disease in glaucoma
families. Typical glaucoma develops because of increased intraocular pressure (IOP) …

GLP-1R agonist NLY01 reduces retinal inflammation, astrocyte reactivity, and retinal ganglion cell death secondary to ocular hypertension

JK Sterling, M Adetunji, S Guttha, A Bargoud, K Uyhazi… - Biorxiv, 2020 - biorxiv.org
Glaucoma is the leading cause of irreversible blindness worldwide and is characterized by
the death of retinal ganglion cells. Reduction of intraocular pressure (IOP) is the only …

Neuroprotective strategies in glaucoma

CA Gossman, J Christie, MK Webster… - Current …, 2016 - ingentaconnect.com
Background: Glaucoma is characterized as a neuropathic disease that causes progressive
degeneration of retinal ganglion cells (RGCs) in the retina, resulting in irreversible loss of …

The dawn of neuroprotective therapy for glaucomatous optic neuropathy

T Yamamoto - Nippon Ganka Gakkai Zasshi, 2001 - europepmc.org
Background Neuroprotective therapy for glaucoma can be defined as treatment of the
recalcitrant disease via direct modification of the molecular mechanism involving retinal …

[HTML][HTML] Glioprotection of retinal astrocytes after intravitreal administration of memantine in the mouse optic nerve crush model

R Maciulaitiene, G Pakuliene, S Kaja… - … medical journal of …, 2017 - ncbi.nlm.nih.gov
Background In glaucoma, non-intraocular pressure (IOP)-related risk factors can result in
increased levels of extracellular glutamate, which triggers a cascade of neurodegeneration …

Targets of neuroprotection in glaucoma

S He, DL Stankowska, DZ Ellis… - Journal of Ocular …, 2018 - liebertpub.com
Progressive neurodegeneration of the optic nerve and the loss of retinal ganglion cells is a
hallmark of glaucoma, the leading cause of irreversible blindness worldwide, with primary …

[HTML][HTML] Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma

Z Dong, Y Shinmei, Y Dong, S Inafuku, J Fukuhara… - Heliyon, 2016 - cell.com
Glaucoma is characterized by axonal degeneration of retinal ganglion cells (RGCs) and
apoptotic death of their cell bodies, and lowering intraocular pressure is associated with an …

[HTML][HTML] Neuroprotection in glaucoma: basic aspects and clinical relevance

CY Kuo, CJL Liu - Journal of Personalized Medicine, 2022 - mdpi.com
Glaucoma is a neurodegenerative disease that affects primarily the retinal ganglion cells
(RGCs). Increased intraocular pressure (IOP) is one of the major risk factors for glaucoma …